© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
San Diego - With its acquisition from Bristol-Myers Squibb of worldwide rights and title to Vaniqa (eflornithine hydrochloride) Cream, Women First HealthCare plans to take another pass at providing women with hirsutism a pharmaceutical alternative.